Skip to main content
Fig. 3 | Arthritis Research & Therapy

Fig. 3

From: Comparison of non-radiographic axial spondyloarthritis and ankylosing spondylitis patients – baseline characteristics, treatment adherence, and development of clinical variables during three years of anti-TNF therapy in clinical practice

Fig. 3

Clinical developments according to C-reactive protein (CRP) status at baseline. Mean (95 % CI) developments in visual analog scale (VAS) global, VAS pain, EuroQ ol 5-Dimensions (EQ-5D) utility, and Evaluator’s global assessment of disease activity during 3 years of anti-TNF therapy in patients with non-radiographic axial spondyloarthritis (nr-axSpA) and ankylosing spondylitis (AS), who had CRP elevation (CRP >3.0 mg/l) or did not have CRP elevation (CRP ≤3.0 mg/l) at baseline

Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us